Literature DB >> 11251335

Genetic heterogeneity in hereditary thrombophilia.

P H Reitsma1.   

Abstract

Venous thromboembolism is a multifactorial disease that depends on variable combinations of acquired and genetic risk factors. The genetic risk factors include loss-of-function mutations in the genes that encode proteins with clot-restraining function, and gain-of-function mutations in procoagulant factors. The loss-of-function mutations are heterogeneous and comprise any mutation that impairs gene function. On the whole, these mutations are rare, with fewer than 1/200--500 individuals affected. This low prevalence in the population is probably caused by the loss of mutant alleles from the gene pool through critically ill homozygous subjects. The gain-of-function mutations in procoagulant proteins differ from the loss-of-function mutations in at least three important respects: these are more homogeneous (factor V Leiden and PT 20210), homozygous individuals are relatively mildly affected, and these are relatively prevalent (3--15%) in Caucasian populations. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11251335     DOI: 10.1159/000054157

Source DB:  PubMed          Journal:  Haemostasis        ISSN: 0301-0147


  4 in total

1.  Characterization of immune cells and perforin mutations in familiar venous thromboembolism.

Authors:  Qianglin Duan; Wei Lv; Minjun Yang; Fan Yang; Yongqiang Zhu; Hui Kang; Haoming Song; Shengyue Wang; Hui Dong; Lemin Wang
Journal:  Int J Clin Exp Med       Date:  2015-05-15

2.  VKORC1 variant genotypes influence warfarin response in patients undergoing total joint arthroplasty: a pilot study.

Authors:  Alejandro González Della Valle; Saurabh Khakharia; Charles J Glueck; Nicole Taveras; Ping Wang; Robert N Fontaine; Eduardo A Salvati
Journal:  Clin Orthop Relat Res       Date:  2008-11-26       Impact factor: 4.176

3.  Evaluation of Factor V G1691A, prothrombin G20210A, Factor XIII V34L, MTHFR A1298C, MTHFR C677T and PAI-1 4G/5G genotype frequencies of patients subjected to cardiovascular disease (CVD) panel in south-east region of Turkey.

Authors:  Serdar Oztuzcu; Sercan Ergun; Mustafa Ulaşlı; Gülper Nacarkahya; Yusuf Ziya Iğci; Mehri Iğci; Recep Bayraktar; Ali Tamer; Ecir Ali Çakmak; Ahmet Arslan
Journal:  Mol Biol Rep       Date:  2014-02-15       Impact factor: 2.316

4.  Multilocus genetic risk scores for venous thromboembolism risk assessment.

Authors:  José Manuel Soria; Pierre-Emmanuel Morange; Joan Vila; Juan Carlos Souto; Manel Moyano; David-Alexandre Trégouët; José Mateo; Noémi Saut; Eduardo Salas; Roberto Elosua
Journal:  J Am Heart Assoc       Date:  2014-10-23       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.